{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T01:06:00Z","timestamp":1725584760617},"publisher-location":"Boston, MA","reference-count":51,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461355663"},{"type":"electronic","value":"9781461514633"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/978-1-4615-1463-3_5","type":"book-chapter","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T03:36:42Z","timestamp":1307072202000},"page":"81-92","source":"Crossref","is-referenced-by-count":2,"title":["The Monocytic Component in Myelodysplastic Syndromes"],"prefix":"10.1007","author":[{"given":"Gianluigi","family":"Castoldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Matteo","family":"Rigolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, G., Gralnick, H. & Sultan C. (1982) Proposals for the classification of myelodysplastic syndromes.British Journal of Haematology51, 189\u2013199.","journal-title":"British Journal of Haematology"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","volume":"87","author":"JM Bennett","year":"1994","unstructured":"Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, G., Gralnick, H., Sultan C. & Cox, C. (1994) The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the French-American-British cooperative leukemia group.British Journal of Haematology87, 746\u2013754.","journal-title":"British Journal of Haematology"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0950-3536(96)80035-7","volume":"9","author":"G Castoldi","year":"1996","unstructured":"Castoldi, G. & Cuneo, A. (1996) Special cytological subtypes of acute myeloid leukemias and myelodysplastic syndromes.Bailli\u00e8re\u2019s Clinical Haematology9, 19\u201333.","journal-title":"Bailli\u00e8re\u2019s Clinical Haematology"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/jcp.38.3.301","volume":"38","author":"RE Clark","year":"1985","unstructured":"Clark, R.E., Hoy, T.G. & Jacobs, A. (1985) Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes.Journal of Clinical Pathology38, 301\u2013304.","journal-title":"Journal of Clinical Pathology"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0950-3536(96)80034-5","volume":"9","author":"G De Greef","year":"1996","unstructured":"De Greef, G. & Hagemeijer, A. (1996) Molecular and cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndromes.Bailli\u00e8re\u2019s Clinical Haematology9, 1\u201318.","journal-title":"Bailli\u00e8re\u2019s Clinical Haematology"},{"key":"5_CR6","first-page":"1104","volume":"83","author":"MT Elghetany","year":"1998","unstructured":"Elghetany, M.T. (1998) Surface marker abnormalities in myelodysplastic syndromes.Haematologica83, 1104\u2013115.","journal-title":"Haematologica"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1993.tb03097.x","volume":"84","author":"T Felzmann","year":"1993","unstructured":"Felzmann, T., Gisslinger, H., Krieger, O., Majadic, O., Ludwig, H. & Koller, U. (1993) Imunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndrome.British Journal of Haematology84, 428\u2013435.","journal-title":"British Journal of Haematology"},{"key":"5_CR8","first-page":"191","volume":"82","author":"A Gallagher","year":"1997","unstructured":"Gallagher, A., Darley, R.L. & Padua, R.A. (1997) The molecular basis of myelodysplastic syndromes.Haematologica82, 191\u2013204.","journal-title":"Haematologica"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0145-2126(97)00192-6","volume":"22","author":"U Germing","year":"1998","unstructured":"Germing, U., Gatterman, N., Minning, H., Heyll, A. & Aul, C. (1998) Problems in the classification of CMML \u2014 dysplastic versus proliferative type.Leukemia Research22, 871\u2013878.","journal-title":"Leukemia Research"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","volume":"103","author":"GM Gersuk","year":"1998","unstructured":"Gersuk, G.M., Beckham, C., Laken, M.R., Kiener, P., Anderson, J.E., Farrand, A., Troutt, A.B., Ledbetter, J.A. & Decg, H.J. (1998) A role for tumour necrosis factor alpha, FAS and FAS-ligand in marrow failure associated with myelodysplastic syndromes.British Journal of Haematology103, 176\u2013188.","journal-title":"British Journal of Haematology"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub, T.R., Bvarker, G.F., Lovett, M., et al. (1994) Fusion of PDGF receptor beta a novel etslike gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.Cell77, 307\u2013318.","journal-title":"Cell"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg, P., Cox, C., Le Beau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes.Blood89, 2079\u20132088.","journal-title":"Blood"},{"key":"5_CR13","doi-asserted-by":"crossref","unstructured":"Guyotat, D., Campos, L., Thomas, X., et al. (1990) Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns.","DOI":"10.1002\/ajh.2830340107"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0145-2126(92)90106-H","volume":"16","author":"TJ Hamblin","year":"1992","unstructured":"Hamblin, T.J. (1992) Clinical features of MDS.Leukemia Research16, 89\u201393.","journal-title":"Leukemia Research"},{"key":"5_CR15","first-page":"150","volume":"33","author":"TJ Hamblin","year":"1996","unstructured":"Hamblin, T.J. (1996) Immunological abnormalities in myelodysplastic syndromes.Seminars in Hematology33, 150\u2013162.","journal-title":"Seminars in Hematology"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"ML Harris","year":"1999","unstructured":"Harris, M.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health classification of neoplastic diseases of the hematopoitic and lymphoid tissues: report of the clinical advisory committee meeting \u2014 Airlie House, Virginia, November 1997.Journal of Clinical Oncology17, 3835\u20133849.","journal-title":"Journal of Clinical Oncology"},{"key":"5_CR17","volume-title":"Cancer Cytogenetics. Second Edition John Wiley & Sons","author":"S Heim","year":"1995","unstructured":"Heim, S. & Mitelman, F. (1995) Cancer Cytogenetics. Second Edition John Wiley & Sons, Inc., New York."},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.V67.4.898.898","volume":"67","author":"P Hockland","year":"1986","unstructured":"Hockland, P., Kendrup, G., Griffin, J.D. & Ellegaard, J. (1986) Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies.Blood67, 898\u2013902.","journal-title":"Blood"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/sj.leu.2400844","volume":"11","author":"M Kitagawa","year":"1997","unstructured":"Kitagawa, M., Saito, I., Kuwata, T., Yoshida, S., Yamaguchi, S., Takahashi, M., Tanizawa, M., Kamiyama, R. & Hirokawa, K. (1997) Overexpression of tumor necrosis factor (TNF)alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.Leukemia 112049\u20132054.","journal-title":"Leukemia"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0145-2126(95)00044-O","volume":"9","author":"M Koike","year":"1995","unstructured":"Koike, M., Ishiyama, T., Tomoyasu, S. & Tsuruoka, N. (1995) Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia.Leukemia Research9, 639\u2013644.","journal-title":"Leukemia Research"},{"key":"5_CR21","first-page":"95","volume":"33","author":"PA Kouides","year":"1996","unstructured":"Kouides, P.A. & Bennett, J.M. (1996) Morphology and classification of the myelodysplastic syndromes and their pathologic variants.Seminars in Hematology33, 95\u2013110.","journal-title":"Seminars in Hematology"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1365-2141.1990.tb02582.x","volume":"74","author":"JS Kristensen","year":"1990","unstructured":"Kristensen, J.S. & Hockland, P. (1990) Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes.British Journal of Haematology74, 270\u2013276.","journal-title":"British Journal of Haematology"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/sj.leu.2400794","volume":"11","author":"F Lanza","year":"1997","unstructured":"Lanza, F., Castagnari, B., Rigolin, G., Latorraca, A., Ferrari, L., Bardi, A. & Castoldi, G. (1997) Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts and normal hemopoietic cells.Leukemia 111700\u20131710.","journal-title":"Leukemia"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood.V71.6.1707.1707","volume":"71","author":"J Lyons","year":"1988","unstructured":"Lyons, J., Janssen, J.W., Bartram, C., Layton, M. & Mufti G.J. (1988) Mutations of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.Blood71, 1707\u20131712.","journal-title":"Blood"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","volume":"85","author":"I Maciejewski","year":"1995","unstructured":"Maciejewski, I., Selleri, C., Anderson, S. & Young, N.S. (1995) Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine mediated hematopoietic suppression in vitro.Blood85, 3183\u20133190.","journal-title":"Blood"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V79.1.198.198","volume":"79","author":"MH Mangi","year":"1992","unstructured":"Mangi, M.H. & Mufti, G.J. (1992) Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.Blood79, 198\u2013205.","journal-title":"Blood"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood.V96.6.2012","volume":"96","author":"L Nilsson","year":"2000","unstructured":"Nilsson, L., Astrand-Grunstrom, I., Arvidsson, I., Jacobsson, B., Hellstrom-Lindberg, E. Hast, & Jacobsen, S.E.W. (2000) Isolation and characterization of hematopoietic progenitor\/stem cells in 5q-deleted myelodysplastic syndromes: evidence for the involvement at he hematopoietic stem cell level.Blood96, 212\u20132021.","journal-title":"Blood"},{"key":"5_CR28","first-page":"338","volume":"7","author":"K Ohyashiki","year":"1993","unstructured":"Ohyashiki, K., Yokoyama, K., Kimura, Y., Ohyashiki, J.H., Ito, T., Kuratsuji, T., Komatsumoto, S., Nara, M. & Toyama, K. (1993) Myclodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?Leukemia7, 338\u2013340.","journal-title":"Leukemia"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1365-2141.1996.396933.x","volume":"92","author":"DG Oscier","year":"1996","unstructured":"Oscier, D.G. (1996) Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome?British Journal of Haematology92, 582\u2013586.","journal-title":"British Journal of Haematology"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0145-2126(98)00063-0","volume":"22","author":"DG Oscier","year":"1998","unstructured":"Oscier, D.G. & Chapman, R. (1998) The classification of chronic myelomonocytic leukemia.Leukemia Research22, 879\u2013880.","journal-title":"Leukemia Research"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/sj.leu.2401044","volume":"12","author":"RA Padua","year":"1998","unstructured":"Padua, R.A., Guinn, B.-A., Al-Sabah, A., Smoth, M., Taylor, C., Pettersson, T., Ridge, S., Carter, G., White, D., Oscier, D., Chevret, S. & West, R. (1998) RAS, FMS and P53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.Leukemia12, 887\u2013892.","journal-title":"Leukemia"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1046\/j.1365-2141.1998.00708.x","volume":"101","author":"JE Parker","year":"1998","unstructured":"Parker, J.E. & Mufti, G.J. (1998) Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes.British Journal of Haematology 101220\u2013230.","journal-title":"British Journal of Haematology"},{"key":"5_CR33","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V83.10.2780.2780","volume":"83","author":"J Pedersen-Bjergaard","year":"1994","unstructured":"Pedersen-Bjergaard, J. & Rowley, J.D. (1994) The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.Blood83, 2780\u20132786.","journal-title":"Blood"},{"key":"5_CR34","doi-asserted-by":"crossref","unstructured":"Raza, A., Gezer, S., Mundle, S., Gao, X.-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, & Preisler, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.Blood86, 268276.","DOI":"10.1182\/blood.V86.1.268.bloodjournal861268"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V95.5.1580.005k45_1580_1587","volume":"95","author":"A Raza","year":"2000","unstructured":"Raza, A., Gawl, H., Lisak, L., Andric, T., Dar, S., Adrews, C., Venugopal, P., Gezer S., Gregory, S., Loew, J., Robin, E., Rifkin, S., Hsu, W.-T-. & Huang R.-W. (2000) Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.Blood95, 1580\u20131587.","journal-title":"Blood"},{"key":"5_CR36","first-page":"25","volume":"82","author":"GM Rigolin","year":"1997","unstructured":"Rigolin, G.M., Cuneo, A., Roberti, M.G., Bardi, A. & Castoldi G. (1997) Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.Haematologica82, 25\u201330.","journal-title":"Haematologica"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2141.1998.00963.x","volume":"103","author":"GM Rigolin","year":"1998","unstructured":"Rigolin, G.M., Cuneo, A., Roberti, M.G., Bardi, A., Bigoni, R., Piva, N., Minotto, C., Agostini, P., De Angeli, C., Del Senno, L., Spanedda, R. & Castoldi G.L. (1998) Exposure to myelotoxic agents and myelodysplasia: case-control study and con-elation with clinicobiologic findings.British Journal of Haematology103, 189\u2013197.","journal-title":"British Journal of Haematology"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1046\/j.1365-2141.1999.01781.x","volume":"107","author":"GM Rigolin","year":"1999","unstructured":"Rigolin, G.M., Howard, J., Buggins, A., Sneddon, C., Castoldi, G., Hirst, W.J.R. & Mufti, G. (1999) Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes.British Journal of Haematology107, 844\u2013850.","journal-title":"British Journal of Haematology"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.leu.2401618","volume":"14","author":"C Rosenfeld","year":"2000","unstructured":"Rosenfeld, C. & List, A. (2000) A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies.Leukemia14, 2\u20138.","journal-title":"Leukemia"},{"key":"5_CR40","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1182\/blood.V91.12.4419","volume":"91","author":"T Ross","year":"1998","unstructured":"Ross, T., Bernard, O.A., Berger, R. & Guillard, G.D. (1998) Fusion of Huntingtin interacting protein 1 to platelet derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia wih t(5;7)(g22:g11.2).Blood91, 4419\u20134426.","journal-title":"Blood"},{"key":"5_CR41","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood.V92.8.2886","volume":"92","author":"K Saitoh","year":"1998","unstructured":"Saitoh, K., Miura, I., Takahashi, N. & Miura A.B. (1998) Fluorescent in situ hybridisation of progenitor cells obtained by fluorescent-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.Blood92, 2886\u20132892.","journal-title":"Blood"},{"key":"5_CR42","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V86.4.1525.bloodjournal8641525","volume":"86","author":"Y Sato","year":"1995","unstructured":"Sato, Y., Suto, Y., Pietenpol, J., et al. (1995) TEL and KIP1 define the smallest region on 12p13 in hematopoietic malignancies.Blood86, 1525\u20131533.","journal-title":"Blood"},{"key":"5_CR43","first-page":"486","volume":"4","author":"K Tobal","year":"1990","unstructured":"Tobal, K., Pagliuca, A., Bhatt, B., Bailey, N., Layton, M. & Mufti, G.J. (1990) Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.Leukemia4, 486\u2013489.","journal-title":"Leukemia"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-2141.1984.tb02916.x","volume":"57","author":"G Tricot","year":"1984","unstructured":"Tricot, G., De Wolf-Peeters, C., Hendrickx, B. & Verwlghen, R.L. (1984) I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears.British Journal of Haematology57, 423\u2013430.","journal-title":"British Journal of Haematology"},{"key":"5_CR45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2141.1991.tb04546.x","volume":"79","author":"E. Vandenberghe","year":"1991","unstructured":"Vandenberghe, E., Baens, M., Stul, M., et al. (1991) Alterations of N-ras mutations in a patients with AML M4 and trilineage myelodysplasia.British Journal of Haematology79, 338\u2013340.","journal-title":"British Journal of Haematology"},{"key":"5_CR46","first-page":"714","volume":"8","author":"GEG Verhoef","year":"1994","unstructured":"Verhoef, G.E.G., Demuynk, H., Zachee, P. & Boogaerts, M.A. (1994) Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two.Leukemia8, 714\u2013715.","journal-title":"Leukemia"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1046\/j.1365-2141.1999.01431.x","volume":"105","author":"S Vuckovic","year":"1999","unstructured":"Vuckovic, S., Feamley, D.B., Gunningham, S., Spearing, R.L., Patton, W.N. & Hart, D.N.J. (1999) Dendritic cells in chronic myelomonocytic leukemia.British Journal of Haematology105, 974\u2013985.","journal-title":"British Journal of Haematology"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0165-4608(93)90051-M","volume":"65","author":"JW Wessels","year":"1993","unstructured":"Wessels, J.W., Fibbe, W.E., Van Der Keur, D., et al. (1993) t(5;12)(g31;p12). A clinical entity with features of both myeloid and chronic myelomonocytic leukemia.Cancer Genetics and Cytogenetics65, 7\u201315.","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"5_CR49","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1182\/blood.V85.10.2848.bloodjournal85102848","volume":"85","author":"J Wlodarska","year":"1995","unstructured":"Wlodarska, J., Mecucci, C., Marynen, P., et al. (1995) TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(g33;p13) translocation or its variant t(10;12)(g24;p 13).Blood85, 2848\u20132852.","journal-title":"Blood"},{"key":"5_CR50","first-page":"609","volume":"4","author":"JJ Yunis","year":"1989","unstructured":"Yunis, J.J., Boot, A.J., Mayer, M.G. & Bos, J.L. (1989) Mechanisms of ras mutations in myelodysplastic syndrome.Oncogene4, 609\u2013614.","journal-title":"Oncogene"},{"key":"5_CR51","first-page":"236","volume":"8","author":"B Zanke","year":"1994","unstructured":"Zanke, B., Squire, J., Griesser, H., et al. (1994) A hemopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1832.1.Leukemia8, 236\u2013244.","journal-title":"Leukemia"}],"container-title":["Cancer Treatment and Research","Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-1463-3_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:19:01Z","timestamp":1605680341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-1463-3_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"ISBN":["9781461355663","9781461514633"],"references-count":51,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-1463-3_5","relation":{},"ISSN":["0927-3042"],"issn-type":[{"type":"print","value":"0927-3042"}],"subject":[],"published":{"date-parts":[[2001]]}}}